Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc. | 292 | ACCESSWIRE | Focus on Regenerative Medicine Combined with Best-in-Class Aesthetics Device OfferingFRANKLIN, WI / ACCESSWIRE / April 24, 2024 / Tiger Aesthetics Medical, LLC today announced its acquisition of substantially... ► Artikel lesen | |
18.04. | Sientra, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
09.04. | NSE - Sientra, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
08.04. | Delisting of Securities of NanoString Technologies, Inc.; Remark Holdings, Inc.; Sunworks, Inc.; Cyanotech Corporation; Sientra, Inc.; Charge Enterprises, Inc. and others from The Nasdaq Stock Market | 209 | GlobeNewswire (Europe) | NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of NanoString Technologies, Inc. NanoString Technologies, Inc.'s securities... ► Artikel lesen | |
03.04. | Sientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction | 143 | GlobeNewswire (Europe) | Tiger Aesthetics Medical, LLC is the successful bidder for certain assets used in Sientra's breast reconstruction and augmentation business Nuance Intermediary, LLC is the successful bidder for substantially... ► Artikel lesen | |
29.03. | Sientra, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
01.03. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 01.03.2024 | 767 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 01.03.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 01.03.2024.ISIN NameCA29383X1033 ENTHEON... ► Artikel lesen | |
14.02. | Implant Maker Sientra Cleared to Draw Deerfield Bankruptcy Loan | 29 | BNN Bloomberg | ||
13.02. | Sientra Files For Bankruptcy; Stock Tanks 65% | 8 | RTTNews | ||
13.02. | Breast-Implant Maker Sientra Files Bankruptcy After Consumer Pullback | 7 | BNN Bloomberg | ||
13.02. | Sientra seeks buyer during Chapter 11 proceedings | 7 | Investing.com | ||
13.02. | Sientra, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
13.02. | Sientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process | 483 | GlobeNewswire (Europe) | IRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) ("Sientra" or the "Company"), a surgical aesthetics company developing and commercializing safe and innovative solutions... ► Artikel lesen | |
29.01. | Sientra, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
16.01. | Sientra, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
20.12.23 | Sientra, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
13.11.23 | Sientra, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
10.11.23 | Earnings call: Sientra reports challenging Q3 2023 results, expresses optimism for recovery | 6 | Investing.com | ||
09.11.23 | Sientra Inc reports results for the quarter ended in September - Earnings Summary | 3 | Reuters | ||
09.11.23 | Recap: Sientra Q3 Earnings | 1 | Benzinga.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TELADOC HEALTH | 12,126 | -0,23 % | 13 Analysts Assess Teladoc Health: What You Need To Know | ||
UNITEDHEALTH | 462,90 | -0,01 % | UnitedHealth Aktie: Effektive Krisenbewältigung | UnitedHealth Group hat kürzlich technische Probleme bei seiner Technologieeinheit Change Healthcare behoben, die die Verarbeitung von medizinischen Ansprüchen für einige Kunden behindert hatten. Nach... ► Artikel lesen | |
THERMO FISHER | 534,50 | -0,28 % | Q1-Zahlen überzeugen: Starke Nachfrage: Thermo Fisher hebt Gewinnprognose an | © Foto: © Copyright 2024 Thermo Fisher ScientificThermo Fisher Scientific hat die Quartalserwartungen der Wall Street übertroffen und seine Jahresgewinnprognose nach oben korrigiert.Die Aktien des Medizingeräteherstellers... ► Artikel lesen | |
BIOTEST | 28,400 | -1,39 % | Biotest baut aus, während Grifols weiter mit Gotham-Schatten kämpft. Ist die Mutter die spannendere Aktie? | Biotest hat in Wuppertal das 12. Plasmasammel-zentrum in Deutschland offiziell eröffnet. Klares Wachstumsprogramm ganz nach den Wünschen der Hauptaktionärin Grifols, die zuletzt von Shortsellern unter... ► Artikel lesen | |
ROKU | 52,72 | +0,13 % | Roku: Wachstum beschleunigt sich, Verluste weiter reduziert | SAN JOSE, Kalifornien (IT-Times) - Roku, Anbieter von Hard- und Software für Video-Streaming-Services, hat seine Ergebnisse für das Auftaktquartal 2024 veröffentlicht und ein zweistelliges Wachstum... ► Artikel lesen | |
RESMED | 203,80 | 0,00 % | Kurs der ResMed-Aktie verharrt auf Vortags-Niveau (189,60 €) | CODE Der jüngste Kurs betrug 189,60 Euro. Kaum auffällig ist zur Stunde am Aktienmarkt der Kurs von ResMed. Das Papier liegt mit 10,88 Prozent im Plus, verglichen mit der Schlussnotierung vom Vortag.... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 1,504 | +5,47 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen | SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced promising safety and efficacy data from the Company's Phase 2 EVANGELINE... ► Artikel lesen | |
HENRY SCHEIN | 68,74 | +0,59 % | Henry Schein (HSIC) Gears Up for Q1 Earnings: Factors to Note | ||
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 0,138 | +0,58 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States | BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
ZIMMER BIOMET | 111,85 | -1,37 % | SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings? | ||
PETMED EXPRESS | 3,687 | -1,76 % | PetMeds sees double-digit growth boost by recent acquisition | ||
ASENSUS SURGICAL | 0,238 | +1,71 % | Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG | RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) ("Asensus" or the "Company"), a medical device company that is digitizing the interface... ► Artikel lesen | |
TANDEM DIABETES | 33,700 | +2,31 % | Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care | ||
QUIDELORTHO | 37,000 | -0,54 % | QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care... ► Artikel lesen |